NurOwn (MSC-NTF cells)
BCT-101-US
Phase 2 mab completed
Quick answer
NurOwn (MSC-NTF cells) for Multiple Sclerosis, Chronic Progressive is a Phase 2 program (mab) at BRAINSTORM CELL THERAPEUTICS INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BRAINSTORM CELL THERAPEUTICS INC.
- Indication
- Multiple Sclerosis, Chronic Progressive
- Phase
- Phase 2
- Modality
- mab
- Status
- completed